Richard A. Hansen - Publications

Pharmaceutical Sciences University of North Carolina, Chapel Hill, Chapel Hill, NC 
Pharmacy, Epidemiology

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Huang WT, Erickson SR, Hansen RA, Wu CH. The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey. Medicine. 95: e3909. PMID 27336878 DOI: 10.1097/MD.0000000000003909  0.36
2016 Sonawane Deshmukh KB, Qian J, Garza KB, Wright BM, Zeng P, Ganduglia Cazaban CM, Hansen RA. Achieving Adherence After First-Line Antihypertensive Treatment: Should Fixed-Dose Combinations Receive Priority? Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26917089 DOI: 10.1111/jch.12799  0.36
2015 Desai RJ, Thaler KJ, Mahlknecht P, Gartlehner G, McDonagh MS, Mesgarpour B, Mazinanian A, Glechner A, Gopalakrishnan C, Hansen RA. Comparative risk of harm associated with the use of targeted immunomodulators- A systematic review. Arthritis Care & Research. PMID 26663412 DOI: 10.1002/acr.22815  0.36
2015 Garza KB, Owensby JK, Braxton Lloyd K, Wood EA, Hansen RA. Pilot Study to Test the Effectiveness of Different Financial Incentives to Improve Medication Adherence. The Annals of Pharmacotherapy. PMID 26447193 DOI: 10.1177/1060028015609354  0.36
2014 Hansen RA, Zeng P, Ryan P, Gao J, Sonawane K, Teeter B, Westrich K, Dubois RW. Exploration of heterogeneity in distributed research network drug safety analyses. Research Synthesis Methods. 5: 352-70. PMID 26052957 DOI: 10.1002/jrsm.1121  0.36
2014 Wittayanukorn S, Qian J, Westrick SC, Billor N, Johnson B, Hansen RA. Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments. Research in Social & Administrative Pharmacy : Rsap. PMID 25582892 DOI: 10.1016/j.sapharm.2014.12.002  0.36
2014 Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski ML, Farley JF. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis. Journal of Managed Care & Specialty Pharmacy. 20: 1110-20. PMID 25351972 DOI: 10.18553/jmcp.2014.20.11.1110  0.36
2014 Mulherin DW, Hutchison AM, Thomas GJ, Hansen RA, Childress DT. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients. Infection. 42: 999-1005. PMID 25129565 DOI: 10.1007/s15010-014-0671-8  0.36
2014 Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski M, Farley J. Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control study. The Journal of Rheumatology. 41: 2129-36. PMID 25086079 DOI: 10.3899/jrheum.131464  0.36
2014 Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, Jonas DE, Swinson Evans T, Viswanathan M, Lohr KN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. The Journal of Clinical Psychiatry. 75: 477-89; quiz 489. PMID 24922485 DOI: 10.4088/JCP.13r08815  0.36
2014 Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. Cns Drugs. 28: 699-712. PMID 24794101 DOI: 10.1007/s40263-014-0169-z  0.36
2014 Wittayanukorn S, Qian J, Hansen RA. Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. General Hospital Psychiatry. 36: 330-6. PMID 24462337 DOI: 10.1016/j.genhosppsych.2013.12.009  0.36
2014 Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Safety. 37: 19-31. PMID 24338044 DOI: 10.1007/s40264-013-0129-4  0.36
2013 Hansen RA, Farley JF, Maciejewski ML, Ye X, Qian C, Powers B. Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record. Bmc Endocrine Disorders. 13: 24. PMID 23866087 DOI: 10.1186/1472-6823-13-24  0.36
2013 Desai RJ, Williams CE, Greene SB, Pierson S, Hansen RA. Anticoagulant medication errors in nursing homes: characteristics, causes, outcomes, and association with patient harm. Journal of Healthcare Risk Management : the Journal of the American Society For Healthcare Risk Management. 33: 33-43. PMID 23861122 DOI: 10.1002/jhrm.21116  0.36
2013 Wittayanukorn S, Westrick SC, Hansen RA, Billor N, Braxton-Lloyd K, Fox BI, Garza KB. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan. Journal of Managed Care Pharmacy : Jmcp. 19: 385-95. PMID 23697476  0.36
2013 Desai RJ, Williams CE, Greene SB, Pierson S, Caprio AJ, Hansen RA. Analgesic medication errors in North Carolina nursing homes. Journal of Pain & Palliative Care Pharmacotherapy. 27: 125-31. PMID 23458096 DOI: 10.3109/15360288.2013.765531  0.36
2013 Ellis AR, Dusetzina SB, Hansen RA, Gaynes BN, Farley JF, Stürmer T. Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART. Annals of Epidemiology. 23: 204-9. PMID 23419508 DOI: 10.1016/j.annepidem.2013.01.004  0.36
2013 Ellis AR, Dusetzina SB, Hansen RA, Gaynes BN, Farley JF, Stürmer T. Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data. Pharmacoepidemiology and Drug Safety. 22: 138-44. PMID 23280682 DOI: 10.1002/pds.3396  0.36
2013 Desai RJ, Williams CE, Greene SB, Pierson S, Caprio AJ, Hansen RA. Exploratory evaluation of medication classes most commonly involved in nursing home errors. Journal of the American Medical Directors Association. 14: 403-8. PMID 23273854 DOI: 10.1016/j.jamda.2012.11.006  0.36
2012 Dusetzina SB, Weinberger M, Gaynes BN, Farley JF, Sleath B, Hansen RA. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents. Pharmacotherapy. 32: 1085-94. PMID 23208835 DOI: 10.1002/phar.1148  0.36
2012 Farley JF, Hansen RA, Yu-Isenberg KS, Maciejewski ML. Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions. The Primary Care Companion For Cns Disorders. 14. PMID 23106028 DOI: 10.4088/PCC.11m01324  0.36
2012 Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE. Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis. The Annals of Pharmacotherapy. 46: 1491-505. PMID 23092868 DOI: 10.1345/aph.1R203  0.36
2012 Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. Bmc Cardiovascular Disorders. 12: 93. PMID 23092442 DOI: 10.1186/1471-2261-12-93  0.36
2012 Dusetzina SB, Farley JF, Weinberger M, Gaynes BN, Sleath B, Hansen RA. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 63: 1019-25. PMID 22855210 DOI: 10.1176/  0.36
2012 Hansen RA, Maciejewski M, Yu-Isenberg K, Farley JF. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. Psychiatric Services (Washington, D.C.). 63: 920-8. PMID 22706887 DOI: 10.1176/  0.36
2012 Gartlehner G, Thaler K, Hill S, Hansen RA. How should primary care doctors select which antidepressants to administer? Current Psychiatry Reports. 14: 360-9. PMID 22648236 DOI: 10.1007/s11920-012-0283-x  0.36
2012 Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depression and Anxiety. 29: 495-505. PMID 22553134 DOI: 10.1002/da.21951  0.36
2012 Katz AJ, Dusetzina SB, Farley JF, Ellis AR, Gaynes BN, Castillo WC, Stürmer T, Hansen RA. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant. Pharmacotherapy. 32: 234-43. PMID 22392456 DOI: 10.1002/j.1875-9114.2011.01020.x  0.36
2012 Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC, Stürmer T. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. Journal of Clinical Psychopharmacology. 32: 114-9. PMID 22198447 DOI: 10.1097/JCP.0b013e31823f705d  0.36
2012 Hansen RA, Dusetzina SB, Ellis AR, Stürmer T, Farley JF, Gaynes BN. Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies. General Hospital Psychiatry. 34: 192-200. PMID 22079151 DOI: 10.1016/j.genhosppsych.2011.10.001  0.36
2011 Dusetzina SB, Gaynes BN, Weinberger M, Farley JF, Sleath B, Hansen RA. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 62: 1443-9. PMID 22193791 DOI: 10.1176/  0.36
2011 Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine. 155: 772-85. PMID 22147715 DOI: 10.7326/0003-4819-155-11-201112060-00009  0.36
2011 Desai R, Williams CE, Greene SB, Pierson S, Hansen RA. Medication errors during patient transitions into nursing homes: characteristics and association with patient harm. The American Journal of Geriatric Pharmacotherapy. 9: 413-22. PMID 22078862 DOI: 10.1016/j.amjopharm.2011.10.005  0.36
2011 Gaynes BN, Farley JF, Dusetzina SB, Ellis AR, Hansen RA, Miller WC, Stürmer T. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? Depression and Anxiety. 28: 989-98. PMID 21898717 DOI: 10.1002/da.20898  0.36
2011 Farley JF, Wang CC, Hansen RA, Voils CI, Maciejewski ML. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. Psychiatric Services (Washington, D.C.). 62: 747-52. PMID 21724787 DOI: 10.1176/  0.36
2011 Hansen NL, Chandiramani DV, Morse MA, Wei D, Hedrick NE, Hansen RA. Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 17: 125-30. PMID 20147576 DOI: 10.1177/1078155209360853  0.36
2010 Hansen RA, Chen SY, Gaynes BN, Maciejewski ML. Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatric Services (Washington, D.C.). 61: 1232-8. PMID 21123408 DOI: 10.1176/ps.2010.61.12.1232  0.36
2010 Aljadhey H, Tu W, Hansen RA, Blalock S, Brater DC, Murray MD. Risk of hyperkalemia associated with selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety. 19: 1194-8. PMID 20842761 DOI: 10.1002/pds.2011  0.36
2010 Hansen RA, Cornell PY, Ryan PB, Williams CE, Pierson S, Greene SB. Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities. Pharmacoepidemiology and Drug Safety. 19: 1087-94. PMID 20684035 DOI: 10.1002/pds.2024  0.36
2010 Hansen RA, Farley JF, Droege M, Maciejewski ML. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clinical Therapeutics. 32: 1308-19. PMID 20678679 DOI: 10.1016/j.clinthera.2010.07.011  0.36
2010 Chen SY, Hansen RA, Gaynes BN, Farley JF, Morrissey JP, Maciejewski ML. Guideline-concordant antidepressant use among patients with major depressive disorder. General Hospital Psychiatry. 32: 360-7. PMID 20633739 DOI: 10.1016/j.genhosppsych.2010.03.007  0.36
2010 Crespin DJ, Modi AV, Wei D, Williams CE, Greene SB, Pierson S, Hansen RA. Repeat medication errors in nursing homes: Contributing factors and their association with patient harm. The American Journal of Geriatric Pharmacotherapy. 8: 258-70. PMID 20624615 DOI: 10.1016/j.amjopharm.2010.05.005  0.36
2010 Greene SB, Williams CE, Pierson S, Hansen RA, Carey TS. Medication error reporting in nursing homes: identifying targets for patient safety improvement. Quality & Safety in Health Care. 19: 218-22. PMID 20123759 DOI: 10.1136/qshc.2008.031260  0.36
2010 Maciejewski ML, Farley JF, Hansen RA, Wei D, Harman JS. Part D plan enrollment by uninsured medicare beneficiaries. Medical Care. 48: 183-6. PMID 20057332 DOI: 10.1097/MLR.0b013e3181bd4e0a  0.36
2010 Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatric Services (Washington, D.C.). 61: 81-5. PMID 20044424 DOI: 10.1176/ps.2010.61.1.81  0.36
2010 Hansen RA, Dusetzina SB, Dominik RC, Gaynes BN. Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiology and Drug Safety. 19: 33-7. PMID 19998397 DOI: 10.1002/pds.1881  0.36
2009 Thaler K, Chandiramani DV, Hansen RA, Gartlehner G. Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project. Biologics : Targets & Therapy. 3: 485-98. PMID 20054439 DOI: 10.2147/BTT.S3579  0.36
2009 Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. Journal of the American Pharmacists Association : Japha. 49: 760-8. PMID 19926556 DOI: 10.1331/JAPhA.2009.08184  0.36
2009 Gartlehner G, Thaler K, Hansen RA, Gaynes BN. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Safety. 32: 1159-73. PMID 19916583 DOI: 10.2165/11318930-000000000-00000  0.36
2009 Little A, Hansen RA, Gartlehner G, Gray C. Impact of the STAR*D trial from the perspective of the payer. Psychiatric Services (Washington, D.C.). 60: 1463-5. PMID 19880462 DOI: 10.1176/  0.36
2009 Gartlehner G, Thieda P, Hansen RA, Morgan LC, Shumate JA, Nissman DB. Inadequate reporting of trials compromises the applicability of systematic reviews. International Journal of Technology Assessment in Health Care. 25: 323-30. PMID 19619351 DOI: 10.1017/S0266462309990122  0.36
2009 Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Research in Social & Administrative Pharmacy : Rsap. 5: 143-53. PMID 19524862 DOI: 10.1016/j.sapharm.2008.06.004  0.36
2009 Gartlehner G, Hansen RA. Are some antidepressants better than others? Nature Reviews. Neurology. 5: 239-40. PMID 19488078 DOI: 10.1038/nrneurol.2009.51  0.36
2009 Gartlehner G, Gaynes BN, Hansen RA, Lohr KN. Ranking antidepressants. Lancet (London, England). 373: 1761; author reply 1. PMID 19465225 DOI: 10.1016/S0140-6736(09)60978-8  0.36
2009 Dorn SD, Farley JF, Hansen RA, Shah ND, Sandler RS. Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions. Gastroenterology. 137: 518-24, 524.e1-2. PMID 19445943 DOI: 10.1053/j.gastro.2009.05.005  0.36
2009 Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. The Annals of Pharmacotherapy. 43: 413-22. PMID 19261962 DOI: 10.1345/aph.1L496  0.36
2009 Hansen RA, Song L, Moore CG, Gilsenan AW, Kim MM, Calloway MO, Murray MD. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials. Pharmacotherapy. 29: 255-62. PMID 19249945 DOI: 10.1592/phco.29.3.255  0.36
2009 Hansen RA, Moore CG, Dusetzina SB, Leinwand BI, Gartlehner G, Gaynes BN. Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 29: 91-103. PMID 19141788 DOI: 10.1177/0272989X08323298  0.36
2008 Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Annals of Internal Medicine. 149: 734-50. PMID 19017592  0.36
2008 Hansen RA, Tu W, Wang J, Ambuehl R, McDonald CJ, Murray MD. Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy. 28: 1325-34. PMID 18956992 DOI: 10.1592/phco.28.11.1325  0.36
2008 Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE, Lohr KN. Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Safety. 31: 851-65. PMID 18759509 DOI: 10.2165/00002018-200831100-00004  0.36
2008 Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clinical Interventions in Aging. 3: 211-25. PMID 18686744  0.36
2008 Krebs EE, Gaynes BN, Gartlehner G, Hansen RA, Thieda P, Morgan LC, DeVeaugh-Geiss A, Lohr KN. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics. 49: 191-8. PMID 18448772 DOI: 10.1176/appi.psy.49.3.191  0.36
2008 Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN. Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. International Clinical Psychopharmacology. 23: 170-9. PMID 18408531 DOI: 10.1097/YIC.0b013e3282f4224a  0.36
2008 Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Annals of Internal Medicine. 148: 124-34. PMID 18025440  0.36
2008 Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clinical Rheumatology. 27: 67-76. PMID 17570009 DOI: 10.1007/s10067-007-0654-6  0.36
2007 Hansen RA, Henley AC, Brouwer ES, Oraefo AN, Roth MT. Geographic Information System mapping as a tool to assess nonresponse bias in survey research. Research in Social & Administrative Pharmacy : Rsap. 3: 249-64. PMID 17945157 DOI: 10.1016/j.sapharm.2006.10.001  0.36
2007 Hansen RA, Gartlehner G, Powell GE, Sandler RS. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 729-35. PMID 17481964 DOI: 10.1016/j.cgh.2007.02.016  0.36
2007 Fu AZ, Liu GG, Christensen DB, Hansen RA. Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 10: 128-36. PMID 17391421 DOI: 10.1111/j.1524-4733.2006.00159.x  0.36
2007 Hansen RA, Gartlehner G, Lohr KN, Kaufer DI. Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis. Drugs & Aging. 24: 155-67. PMID 17313203 DOI: 10.2165/00002512-200724020-00007  0.36
2007 Yite JL, Farley JF, Hansen RA. Promotion and market share in the proton pump inhibitor market: A case study Journal of Pharmaceutical Marketing and Management. 17: 39-59. DOI: 10.1300/J058v17n03_04  0.36
2007 Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. Authors' reply to comment on: a simple and valid tool distinguished efficacy from effectiveness studies Journal of Clinical Epidemiology. 60: 755. DOI: 10.1016/j.jclinepi.2006.12.007  0.36
2006 Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. The Journal of Rheumatology. 33: 2398-408. PMID 17225293  0.36
2006 Hansen RA, Roth MT, Brouwer ES, Herndon S, Christensen DB. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. Journal of the American Pharmacists Association : Japha. 46: 700-6. PMID 17176685  0.36
2006 Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology. 59: 1040-8. PMID 16980143 DOI: 10.1016/j.jclinepi.2006.01.011  0.36
2006 Fu AZ, Christensen DB, Hansen RA, Liu GG. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis. Clinical Therapeutics. 28: 979-89. PMID 16860180 DOI: 10.1016/j.clinthera.2006.06.011  0.36
2006 Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, Russo MW, Sandler RS. The burden of gastrointestinal and liver diseases, 2006. The American Journal of Gastroenterology. 101: 2128-38. PMID 16848807 DOI: 10.1111/j.1572-0241.2006.00723.x  0.36
2006 Gartlehner G, Hansen RA, Carson SS, Lohr KN. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Annals of Family Medicine. 4: 253-62. PMID 16735528 DOI: 10.1370/afm.517  0.36
2006 Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, Carey TS. Types of medication errors in North Carolina nursing homes: a target for quality improvement. The American Journal of Geriatric Pharmacotherapy. 4: 52-61. PMID 16730621 DOI: 10.1016/j.amjopharm.2006.03.007  0.36
2006 Trygstad TK, Hansen RA, Wegner SE. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. Journal of Managed Care Pharmacy : Jmcp. 12: 108-20. PMID 16515369  0.36
2006 Gartlehner G, Hansen RA, Carson SS, Lohr KN. Corticosteroids benefit patients with moderate to severe COPD Journal of Family Practice. 55: 756.  0.36
2005 Schommer JC, Hansen RA. The study of direct-to-consumer advertising for prescription drugs. Research in Social & Administrative Pharmacy : Rsap. 1: 348-68. PMID 17138482 DOI: 10.1016/j.sapharm.2005.03.006  0.36
2005 Hansen RA, Droege M. Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrum. Research in Social & Administrative Pharmacy : Rsap. 1: 331-47. PMID 17138481 DOI: 10.1016/j.sapharm.2005.03.005  0.36
2005 Schommer JC, Singh RL, Hansen RA. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Research in Social & Administrative Pharmacy : Rsap. 1: 231-50. PMID 17138476 DOI: 10.1016/j.sapharm.2005.03.009  0.36
2005 Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Research in Social & Administrative Pharmacy : Rsap. 1: 139-57. PMID 17138472 DOI: 10.1016/j.sapharm.2005.03.002  0.36
2005 Hansen RA, Shaheen NJ, Schommer JC. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clinical Therapeutics. 27: 1478-87. PMID 16291421 DOI: 10.1016/j.clinthera.2005.09.006  0.36
2005 Blalock SJ, Byrd JE, Hansen RA, Yamanis TJ, McMullin K, DeVellis BM, DeVellis RF, Panter AT, Kawata AK, Watson LC, Jordan JM. Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults. The American Journal of Geriatric Pharmacotherapy. 3: 168-79. PMID 16257819 DOI: 10.1016/S1543-5946(05)80023-6  0.36
2005 Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Annals of Internal Medicine. 143: 415-26. PMID 16172440  0.36
2005 Cline RR, Farley JF, Hansen RA, Schommer JC. Osteoporosis beliefs and antiresorptive medication use. Maturitas. 50: 196-208. PMID 15734601 DOI: 10.1016/j.maturitas.2004.05.004  0.36
2005 Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. International Clinical Psychopharmacology. 20: 59-69. PMID 15729080 DOI: 10.1097/00004850-200503000-00001  0.36
2004 Farley JF, Cline RR, Hansen RA. Resorptive drug use among community-dwelling women in Minnesota. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 61: 1577-85. PMID 15372831 DOI: 10.1093/ajhp/61.15.1577  0.36
2003 Schommer JC, Mott DA, Hansen RA, Cline RR. Selected characteristics of senior citizens prescription drug payment and procurement in 1998 and 2001. Journal of Managed Care Pharmacy : Jmcp. 9: 408-15. PMID 14613438 DOI: 10.18553/jmcp.2003.9.5.408  0.36
Show low-probability matches.